Expression proteomics study to determine metallodrug targets and optimal drug combinations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Expression proteomics study to determine metallodrug targets and optimal drug combinations ; volume:7 ; number:1 ; day:8 ; month:5 ; year:2017 ; pages:1-11 ; date:12.2017
Scientific reports ; 7, Heft 1 (8.5.2017), 1-11, 12.2017
- Urheber
-
Lee, Ronald F. S.
Chernobrovkin, Alexey
Rutishauser, Dorothea
Allardyce, Claire S.
Hacker, David
Johnsson, Kai
Zubarev, Roman A.
Dyson, Paul J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-01643-1
- URN
-
urn:nbn:de:101:1-2019080921302455310206
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Ronald F. S.
- Chernobrovkin, Alexey
- Rutishauser, Dorothea
- Allardyce, Claire S.
- Hacker, David
- Johnsson, Kai
- Zubarev, Roman A.
- Dyson, Paul J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Optimal drug combinations and minimal hitting sets
Rational combinations of immunotherapeutics that target discrete pathways
Optimal Portfolio Choice Under Decision-Based Model Combinations
Screening drug target combinations in disease-related molecular networks
Optimal Combinations of Income Tax and Subsidies for Education
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
The Scottish Structural Proteomics Facility: targets, methods and outputs
Proteomics of AML1/ETO Target Proteins: AML1–ETO Targets a C/EBP–NM23 Pathway
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Chemical proteomics strategies for elucidation of cellular steroid hormone targets
A decision support system to determine optimal ventilator settings
Optimal drug combinations and minimal hitting sets
Rational combinations of immunotherapeutics that target discrete pathways
Optimal Portfolio Choice Under Decision-Based Model Combinations
Screening drug target combinations in disease-related molecular networks
Optimal Combinations of Income Tax and Subsidies for Education
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
The Scottish Structural Proteomics Facility: targets, methods and outputs
Proteomics of AML1/ETO Target Proteins: AML1–ETO Targets a C/EBP–NM23 Pathway
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Chemical proteomics strategies for elucidation of cellular steroid hormone targets
A decision support system to determine optimal ventilator settings
Optimal drug combinations and minimal hitting sets
Rational combinations of immunotherapeutics that target discrete pathways
Optimal Portfolio Choice Under Decision-Based Model Combinations
Screening drug target combinations in disease-related molecular networks
Optimal Combinations of Income Tax and Subsidies for Education
Synergistic Target Combinations Against Obesity: Focus on MCHR1/H3R Modulation
Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis
The Scottish Structural Proteomics Facility: targets, methods and outputs
Proteomics of AML1/ETO Target Proteins: AML1–ETO Targets a C/EBP–NM23 Pathway
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Chemical proteomics strategies for elucidation of cellular steroid hormone targets